Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 4
2(33.3%)
6Total
N/A(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02848391Not ApplicableCompleted

Hypobaric Flight Simulation in COPD Patients

Role: lead

NCT01609244Not ApplicableCompleted

Bilevel Versus Servoventilation in Complex Sleep Apnea

Role: lead

NCT01256645Phase 4Unknown

Transfusion Strategies in Weaning Patients

Role: lead

NCT00366912Not ApplicableTerminated

Unloading Respiratory Muscles During NIV: Comparison of a Spontaneous and Auto-adjusting Controlled Mode

Role: lead

NCT00415896Not ApplicableUnknown

Impact of Respiratory Muscle Unloading on Respiratory Muscle Endurance

Role: lead

NCT00291460Phase 4Unknown

Inspiratory Muscle Training in Hypercapnic COPD

Role: lead

All 6 trials loaded